Penserra Capital Management LLC Alx Oncology Holdings Inc Transaction History

Penserra Capital Management LLC

  • $4.61 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$21.49 - $74.4 $19,878 - $68,820
-925 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$52.51 - $80.91 $525 - $809
10 Added 1.09%
925 $68,000
Q2 2021

Aug 12, 2021
BUY
$52.2 - $75.23 $783 - $1,128
15 Added 1.67%
915 $50,000
Q1 2021

May 13, 2021
BUY
$62.84 - $87.68 $3,142 - $4,384
50 Added 5.88%
900 $66,000
Q4 2020

Feb 12, 2021
BUY
$34.11 - $112.26 $28,993 - $95,421
850 New
850 $73,000

Others Institutions Holding ALXO

# of Institutions
101
Shares Held
39.7M
Call Options Held
134K
Put Options Held
17.4K
View Full List

About ALX ONCOLOGY HOLDINGS INC

ALXO Quotes by TradingView
  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $68.9M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email